MicroPort® NeuroTech Attends Second Shaolin Interventional Neurosurgical Conference and 5th Central China Cerebrovascular Disease Forum - 16 Nov 2019
MicroPort NeuroTech (Shanghai) Co., Ltd. ("MicroPort® NeuroTech") atte...Firehawk® Project Wins 2019 PMI (China) Project Management Award – Excellent Project - 07 Nov 2019
On October 26, 2019, the project of Firehawk® Rapamycin Target Eluting...MicroPort® CardioFlow Attends the Fifth Edition of PCR-CIT China Chengdu Valves - 27 Oct 2019
The fifth edition of PCR-CIT China Chengdu Valves under the joint orga...MicroPort® Won APQO Innovation Class Award 2019 - 25 Oct 2019
The 25th Asia Pacific Quality Organization (APQO) International Confer...MicroPort® Wins First Edition of "Shanghai Municipality Intellectual Property Innovation Award" - 23 Oct 2019
On October 21, 2019, MicroPort® won the first edition of Shanghai Muni...MicroPort® Exhibits VitaFlow® Integrated Solution at Third Edition of China Structure Week - 18 Oct 2019
On October 7-13, 2019, the China Structure Week 2019 and 3rd Edition o...MicroPort® Firesorb® Pivotal Study (FUTURE III) Holds National Investigator Kick-off Meeting in Beijing - 18 Oct 2019
On October12, 2019, FUTURE-III, a pivotal Study for Firesorb® Bioresor...Endovastec™ Post-marketing Clinical Study of Minos® Abdominal Aortic Stent-Graft and Delivery System Noted in Shanghai - 29 Sep 2019
On September 27, 2019, the Post-marketing Clinical Study of Minos® Abd...Inauguration of MicroPort® Orthopedics' International Shared Services Center in Costa Rica - 21 Sep 2019
MicroPort® Orthopedics' International Shared Services Center in Costa ...MicroPort® CRM Announces First Implant in Japan of the New Eno™ Pacemaker Family, World's Smallest 1.5T & 3T MRI Conditional Pacemakers* - 15 Sep 2019
MicroPort® CRM, which is a business unit of MicroPort Scientific Corpo...MicroPort® CRM Japan Starts Direct Sales Operations in Japan and Launches the New ENO™ Pacemaker Family - 04 Sep 2019
MicroPort® CRM Japan Co. Ltd. is pleased to announce it has started di...MicroPort® Announces Interim Results for the Six Months Ended June 30, 2019 - 28 Aug 2019
MicroPort Scientific Corporation (the "Company", or "MicroPort®", Stoc...Endovastec™, a Subsidiary of MicroPort®, Listed on the STAR Market of the Shanghai Stock Exchange - 24 Jul 2019
Shanghai MicroPort Endovascular MedTech Co., Ltd. ("Endovastec™", or "...MicroPort® Orthopedics Announces Launch of its Evolution® NitrX™ Knee - 21 Jul 2019
MicroPort® Orthopedics, a medical device company that develops and man...VitaFlow® Transcatheter Aortic Valve and Delivery System Receives NMPA Approval - 14 Jul 2019
On July 12th, Shanghai MicroPort CardioFlow Medtech Co., Ltd. ("MicroP...MicroPort® EP Obtains Approval for OptimAblate™ Cardiac RF Generator from National Medical Products Administration of China (NMPA) - 08 Jul 2019
Shanghai MicroPort EP MedTech Co., Ltd. (“MicroPort® EP”) recently obt...